DV Biomed Co., Ltd. (TPEX:6539)
47.00
-3.90 (-7.66%)
Apr 20, 2026, 11:45 AM CST
DV Biomed Revenue
In the year 2025, DV Biomed had annual revenue of 794.18M TWD with 38.46% growth. DV Biomed had revenue of 387.75M in the half year ending June 30, 2025, with 19.17% growth.
Revenue
794.18M
Revenue Growth
+38.46%
P/S Ratio
1.56
Revenue / Employee
2.44M
Employees
326
Market Cap
1.24B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 794.18M | 220.60M | 38.46% |
| Dec 31, 2024 | 573.57M | -45.28M | -7.32% |
| Dec 31, 2023 | 618.85M | -1.25B | -66.84% |
| Dec 31, 2022 | 1.87B | 38.99M | 2.13% |
| Dec 31, 2021 | 1.83B | 15.42M | 0.85% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| TSH Biopharm Corporation | 1.34B |
| Prince Pharmaceutical | 1.06B |
| Excelsior Biopharma | 898.26M |
| Anxo Pharmaceutical | 883.22M |
| Winston Medical Supply | 700.07M |
| GeneFerm Biotechnology | 677.10M |
| Tien Liang BioTech | 511.79M |
| Bioray Biotech | 230.06M |